US Supreme Court Asked to Reconsider Gene Patents
By Ruth Saunders,
BioNews
| 10. 01. 2012
The American Civil Liberties Union (ACLU) has asked the US Supreme Court to reconsider its decision to uphold the patent held by Myriad Genetics on two human genes associated with hereditary breast and ovarian cancers.
The lawsuit was filed by ACLU and the Public Patent Foundation on behalf of medical associations including the Association for Molecular Pathology, scientists, patients and women's health groups. It is the latest part of an ongoing battle over the validity of the patents held by Myriad Genetics. The lawsuit claims the patents are illegal and will both hamper scientific research and limit accessibility to medical care.
The ruling over the gene patents has been going back and forth since March 2010, when a district court declared the patents invalid, but was later overturned by the Court of Appeal for the Federal Circuit (CAFC). The decision was passed on to the Supreme Court, which asked the CAFC to reassess their judgement taking into consideration the Supreme Court's recent ruling against a similar patent.
The genes in question, BRCA1 and BRCA2, can be used to detect the...
Related Articles
By Pete Shanks
| 02.27.2026
Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The study’s plan echoed the notorious Tuskegee disaster, withholding safe, effective vaccines against hepatitis B from some newborns while inoculating others. It was to be financed by the U.S. but performed by a controversial Danish team. That project provoked a multi-national outcry, leading to a remarkable response from the World Health Organization:
WHO has significant concerns regarding the study’s scientific...
By Jenn White, NPR | 02.26.2026
By Kiana Jackson and Shannon Stubblefield, New Disabled South | 02.09.2026
"MC0_8230" via Wikimedia Commons licensed under CC by 2.0
This report documents a deliberate assault on disabled people in the United States. Not an accident. Not a series of bureaucratic missteps. An assault that has been coordinated across agencies...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
